ANTHEM.NS(ANTHEM.NS)
ANTHEM.NS
No analyst ratings available
No analyst price targets available for ANTHEM.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $25.42B | $30.66B | $36.36B |
| Low | $25.12B | $29.74B | $35.22B |
| High | $25.81B | $31.57B | $38.01B |
| EBITDA Avg | $10.20B | $12.30B | $14.59B |
| Low | $10.08B | $11.93B | $14.13B |
| High | $10.36B | $12.67B | $15.25B |
| EBIT Avg | $8.78B | $10.59B | $12.56B |
| Low | $8.68B | $10.27B | $12.17B |
| High | $8.92B | $10.91B | $13.13B |
| Net Income Avg | $7.21B | $8.57B | $10.66B |
| Low | $6.90B | $8.41B | $9.73B |
| High | $7.41B | $8.98B | $11.00B |
| EPS Avg | $12.79 | $15.29 | $18.45 |
| Low | $12.16 | $14.83 | $17.15 |
| High | $13.06 | $15.83 | $19.39 |
| Analysts (Rev / EPS) | 7 / 5 | 7 / 5 | 4 / 4 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $5.50B | $4.23B |
| Low | $5.50B | $4.23B |
| High | $5.50B | $4.23B |
| EBITDA Avg | $2.21B | $1.70B |
| Low | $2.21B | $1.70B |
| High | $2.21B | $1.70B |
| EBIT Avg | $1.90B | $1.46B |
| Low | $1.90B | $1.46B |
| High | $1.90B | $1.46B |
| Net Income Avg | $1.36B | $1.76B |
| Low | $1.36B | $1.76B |
| High | $1.36B | $1.76B |
| EPS Avg | $2.40 | $3.10 |
| Low | $2.40 | $3.10 |
| High | $2.40 | $3.10 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |